Back to search

North Carolina State University

Life Cycle Assessment in Pharmaceutical Applications.

Abstract

dc:description.abstract

In the present work, life cycle information is developed to provide environmental input into process development and chemical selection within the pharmaceutical industry. The evaluation at various stages of the development process for Sertraline Hydrochloride, an effective chiral antidepressant, was conducted. This evaluation included the Life Cycle Inventory (LCI) and further Life Cycle Assessment (LCA) to compare several synthetic routes and production processes of this pharmaceutical product. To complete the Sertraline analysis, a methodology to generate gate-to-gate life cycle information of chemical substances was developed based on a transparent methodology of chemical engineering process design (an ab initio approach). In the broader concept of an LCI, the information of each gate-to-gate module can be linked accordingly in a production chain, including the extraction of raw materials, transportation, disposal, reuse, etc. to provide a full cradle-to-gate evaluation. Furthermore, the refinery, energy and treatment sub-modules were developed to assess the environmental burdens related to energy requirements and waste treatment. Finally, the concept of a 'Clean/Green Technology Guide' was also proposed as an expert system that would provide the scientists with comparative environmental and safety performance information on available technologies for commonly performed unit operations in the pharmaceutical industry. With the expected future application of computer-aid techniques for combinatorial synthesis, an increase of the number of parallel routes to be evaluated in the laboratory scale might be predicted. Life cycle information might also be added to this combinatorial synthesis approach for R&D. This input could be introduced in the earlier stages of process design in order to select cleaner materials or processes using a holistic perspective. This life cycle approach in pharmaceutical synthesis is intended to facilitate the evaluation, comparison, and selection of alternative synthesis routes, by incorporating the overall environmental impact of routes.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jimenez-Gonzalez, Concepcion
Advisors dc:contributor.advisor
  • Michael R. Overcash, Chair
  • PK Lim, Member
  • Samuel Winchester, Member
  • Christine S. Grant, Member

Rights

dc:rights
Statement dc:rights
  • I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to NC State University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.

Identifiers

dc:identifier.*
Dc Identifier Other
etd-20020207-155355

Chain of custody

source
Harvested from
North Carolina State University
Base URL
repository.lib.ncsu.edu/server/oai/request
Last updated
2026-08-21
Source record
OAI-PMH GetRecord
related terms
citation

Jimenez-Gonzalez, Concepcion. Life Cycle Assessment in Pharmaceutical Applications.. 2002. http://www.lib.ncsu.edu/resolver/1840.16/5635